These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12769247

  • 1. Sustained use of nesiritide to aid in bridging to heart transplant.
    Hill JA, Hsu K, Pauly DF, Schofield R, Aranda JM.
    Clin Cardiol; 2003 May; 26(5):211-4. PubMed ID: 12769247
    [Abstract] [Full Text] [Related]

  • 2. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 3. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P.
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 11. Nesiritide for the treatment of congestive heart failure.
    Iyengar S, Feldman DS, Trupp R, Abraham WT.
    Expert Opin Pharmacother; 2004 Apr 15; 5(4):901-7. PubMed ID: 15102572
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM, Goa KL.
    Drugs; 2003 Apr 15; 63(1):47-70. PubMed ID: 12487622
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
    Burger AJ, Elkayam U, Neibaur MT, Haught H, Ghali J, Horton DP, Aronson D.
    Am J Cardiol; 2001 Jul 01; 88(1):35-9. PubMed ID: 11423055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
    Colbert K, Greene MH.
    Crit Care Nurs Q; 2003 Jul 01; 26(1):40-4. PubMed ID: 12669946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. B-type natriuretic peptide: from bench to bedside.
    Adams KF, Mathur VS, Gheorghiade M.
    Am Heart J; 2003 Feb 01; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.